Skip to main
OHI

OHI Stock Forecast & Price Target

OHI Analyst Ratings

Based on 8 analyst ratings
Buy
Strong Buy 25%
Buy 25%
Hold 50%
Sell 0%
Strong Sell 0%

Bulls say

Omega Healthcare Investors Inc has raised its 2025 FFO estimate to $2.81 per share from $2.78 per share, reflecting higher expected investment volume. Additionally, the normalized FFO estimate has been increased to $2.95 per share from $2.89 per share when excluding certain one-time expenses. The company's stock is demonstrating strong performance, advancing 12% year-to-date compared to 4% for the Vanguard Real Estate ETF (VNQ), and is trading near the higher end of its 10-year valuation range, indicating positive investor sentiment and solid fundamentals.

Bears say

Omega Healthcare Investors Inc. faces significant challenges due to ongoing operator difficulties, contributing to a negative sentiment regarding the company's valuation metrics. Although there is a slight improvement in the estimated 2026 adjusted funds from operations (FFO), rising from $3.13 per share to $3.22 per share, it remains above the market consensus of $3.10 per share for core FFO. These factors suggest structural weaknesses in the operational landscape that could hinder Omega's financial performance and investor confidence.

OHI has been analyzed by 8 analysts, with a consensus rating of Buy. 25% of analysts recommend a Strong Buy, 25% recommend Buy, 50% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Omega Healthcare Investors and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Omega Healthcare Investors (OHI) Forecast

Analysts have given OHI a Buy based on their latest research and market trends.

According to 8 analysts, OHI has a Buy consensus rating as of Dec 25, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $46.62, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $46.62, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Omega Healthcare Investors (OHI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.